Abraham Ceesay — Chief Operating Officer at scPharmaceuticals

Mr. Abraham Ceesay, also known as Abe, has been the Chief Operating Officer at scPharmaceuticals LLC since March 2016. Mr. Ceesay has an extensive experience in the launch and growth of innovative therapeutic products and a strong track record in the leadership of global commercial teams. Mr. Ceesay served as the Vice President of Sales & Marketing Operations at Keryx Biopharmaceuticals Inc. until March 25, 2016. Mr. Ceesay served as the Vice President of Marketing & Operations at Keryx Biopharmaceuticals Inc. since February 18, 2014 and also served as its Vice President, Sales, Marketing and Commercial Operations, where he developed the commercial organization and strategy for its inaugural product Auryxia??. Mr. Ceesay developed and led all aspects of the Zerenex(TM) launch strategy and execution, including brand planning, forecasting and analysis, marketing operations and patient access programs. Mr. Ceesay served as the Vice President of Marketing at Ironwood Pharmaceuticals for four years, where he held responsibility for the management of the U.S. P&L, leadership of the Linzess(R) brand team and co-promotion collaboration with Forest Laboratories. In his role, Mr. Ceesay developed and led all facets of the Linzess(R) launch strategy and also led the cross functional U.S. Operating Team responsible for the commercial and development decisions to support the commercialization of Linzess(R). Previous to his career with Ironwood, Mr. Ceesay spent eight years at Genzyme/Sanofi, initially as a field sales specialist and ultimately as the Director, Renal Global Marketing, in which capacity he held marketing responsibility for its renal franchise (Renagel(R), Renvela(R), Hectorol(R)). Over the course of his career at Genzyme, Mr. Ceesay developed and implemented brand strategies for the global renal franchise, including all marketing facets of the Renvela(R) launch strategy. Mr. Ceesay holds a B.S. in Health Education & Physiology from Ithaca College and a Masters of Business Administration from Suffolk University's Sawyer School of Management.